North America Western Blotting Market Forecast Analysis 2024-2032

North America Western Blotting Market Forecast Analysis 2024-2032

Triton’s research analysis states that the western blotting market in North America is estimated to gain revenue at a CAGR of 3.74% over the forecast years 2024-2032.

Several key factors drive the western blotting market in North America. Many pharmaceutical and biotechnology R&D centers are located in the region, benefiting from advanced technology and skilled personnel who are actively working on HIV/AIDS vaccine development. Additionally, extensive scientific and medical research efforts are underway, supported by significant funding from the National Institutes of Health (NIH), particularly in areas like biotechnology and human health. This funding, combined with research advancements in sectors like agriculture and biotechnology, further boosts the demand for western blotting products across the Americas during the forecast period.

The countries researched in this region include the United States and Canada.

The United States holds the largest market share, achieving around $268.52 million in 2023.

• As per HIV.gov, approximately 1.2 million people are living with HIV in the US and around 13% are unaware of their status. Thus, the demand for accurate diagnostic tools like western blotting remains high to identify and confirm infections.
• In 2022, an estimated 31,800 new HIV cases were reported in America, increasing the need for western blotting in confirming diagnoses and supporting early treatment efforts.
• Individuals diagnosed with HIV require regular testing and monitoring, driving continued demand for western blotting products in clinical and diagnostic settings.
• HIV awareness programs and testing initiatives, particularly in low- and middle-income regions, create further demand for western blotting products, contributing to the market growth of western blotting.

Western Blotting Market Forecast for Canada

According to the Cancer Canadian Statistics 2023 report, an estimated 2 in 5 Canadians will develop cancer in their lifetime. The report also predicted 239,100 new cancer diagnoses and 86,700 cancer mortalities in 2023 alone. These alarming figures drive the demand for advanced diagnostic tools like western blotting techniques, which play a crucial role in cancer research and diagnostics by detecting specific proteins linked to the disease. As cancer incidence rises, the need for accurate testing and ongoing research grows, leading to increased demand for western blotting products and contributing to the market’s expansion in this country.

The studied market is categorized into application, product, and end-user. The end-user segment comprises pharmaceutical & biotechnology companies, research institutes, diagnostic centers, and other end-users. Pharmaceutical and biotechnology companies utilize western blotting techniques in the development of new drugs. The growing applications of western blotting in sectors like food, beverage, and agriculture have also encouraged these companies to invest in research and development to tackle key issues within these fields. As new diseases continue to emerge, pharmaceutical companies will increasingly rely on western blotting for accurate diagnosis and to gain insights necessary for developing innovative treatments.

Contender Analysis in the Western Blotting Market:

LI-COR Inc (doing business as LI-COR Biosciences) is a medical device company specializing in research services. It provides scientific instruments for plant science research and designs, manufactures, and markets instruments, software, reagents, and integrated systems for various fields, including plant biology, biotechnology, drug discovery, and environmental research. LI-COR’s product range includes genomics reagents, western blot reagents, protease assay reagents, Pearl Cam software, optical imaging reagents, and protein gel combs. These products are used in applications such as soil gas flux, eddy covariance, gas analysis, photosynthesis, and light measurement. The company distributes its products across Africa, Asia, Europe, and America, with its headquarters in Lincoln, Nebraska, USA.

The other important contenders in the western blotting market are Thermo Fisher Scientific, Bio-Rad Technologies, Cell Signaling Technology Inc, Bio-Techne Corporation, and Li-Cor Inc.